Preliminary Results of a Quality Control Study on Involved Node Radiotherapy in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.166_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Outcome and Treatment of Relapsing Early Pet Negative Patients Included in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Prognostic Value of Immunohistochemical Markers in Stage Iii/Iv Classical Hodgkin Lymphoma Treated Frontline in the Lysa Eortc 20012 Randomized Protocol

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Radiation-Induced Second Malignancies After Involved-Node Radiotherapy With Deep-Inspiration Breath-Hold Technique for Early Stage Hodgkin Lymphoma: A Dosimetric Study

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

Brentuximab Vedotin Followed by ABVD +/− Radiotherapy in Patients With Previously Untreated Hodgkin Lymphoma: Final Results of a Pilot Phase II Study

Haematologica
Hematology
2015English

Bendamustine and Rituximab in Elderly Patients With Low-Tumour Burden Follicular Lymphoma. Results of the LYSA Phase II BRIEF Study

British Journal of Haematology
Hematology
2018English

Evita: Phase I/Ii Study of Everolimus Plus Itacitinib in Relapsed/Refractory Classical Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

First Salvage Treatment With Bendamustine and Brentuximab Vedotin in Hodgkin Lymphoma: A Phase 2 Study of Fil Onlus

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Intensity-Modulated Pelvic Node and Bladder Radiotherapy (IMPART) Trial: A Phase II Single-Centre Prospective Study

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2020English

Therapy of Nodal Follicular Lymphoma (WHO Grade 1/2) in Clinical Stage I/Ii Using Response Adapted Involved Site Radiotherapy in Combination With Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and Response Adapted Involved-Site Radiotherapy): A Study Protocol for a Single-Arm, Non-Randomized, Open, National, Multi-Center Phase II Trial

Trials
MedicinePharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy